earnings

NYSE · SOLV
Solventum Corporation
Healthcare · Medical - Care Facilities
$90.06
Up+$0.62 (+0.68%)
Updated Sep 16, 2026, 2:30 PM
SID Score
7.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 14.36B
- P/E ratio
- 9.47
- Dividend yield
- 0.00%
- 52-week range
- $62.38 – $94.16
- Volume
- 1.1M
- Avg. volume
- 1.1M
Price performance
SOLV price history
1M range · 20 trading sessions · Daily adjusted prices
SOLV closed at $90.06 after 20 trading sessions, up 2.98% for the selected period.
- Last close
- $90.06
- Period change
- +2.98%
- Period low
- $87.45
- Period high
- $92.44
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $89.54 | $91.86 | $89.38 | $90.06 | 1.1M |
| Sep 14, 2026 | $88.28 | $90.3203 | $88.045 | $89.82 | 779.29K |
| Sep 11, 2026 | $88.66 | $88.84 | $86.65 | $87.45 | 774.43K |
| Sep 10, 2026 | $89.12 | $90.06 | $87.59 | $87.65 | 709.79K |
| Sep 9, 2026 | $89.22 | $90.22 | $88.8303 | $90.03 | 803.49K |
| Sep 8, 2026 | $90.74 | $91.01 | $89.295 | $90.11 | 1.11M |
| Sep 4, 2026 | $91.40 | $92.275 | $91.375 | $91.69 | 576.35K |
| Sep 3, 2026 | $93.54 | $94.12 | $91.34 | $92.44 | 784.32K |
| Sep 2, 2026 | $91.12 | $93.1099 | $91.12 | $91.90 | 826.11K |
| Sep 1, 2026 | $92.59 | $94.16 | $90.745 | $90.95 | 1.11M |
| Aug 31, 2026 | $90.33 | $91.64 | $90.304 | $91.06 | 926.44K |
| Aug 28, 2026 | $90.98 | $91.70 | $90.69 | $91.12 | 678.87K |
| Aug 27, 2026 | $90.52 | $92.26 | $89.51 | $90.93 | 687.43K |
| Aug 26, 2026 | $91.48 | $92.71 | $91.16 | $91.53 | 1.02M |
| Aug 25, 2026 | $90.79 | $92.05 | $90.35 | $91.61 | 1.05M |
| Aug 24, 2026 | $89.45 | $91.51 | $89.30 | $91.25 | 1.14M |
| Aug 21, 2026 | $88.29 | $89.65 | $87.915 | $89.57 | 925.25K |
| Aug 20, 2026 | $87.09 | $89.44 | $87.03 | $88.61 | 805.06K |
| Aug 19, 2026 | $87.88 | $89.745 | $87.67 | $87.81 | 917.87K |
| Aug 18, 2026 | $87.50 | $88.47 | $87.03 | $87.45 | 1.16M |
Latest SOLV news
The latest Smart Investors Daily articles mentioning SOLV.
Stock researchResearch & News · Analysis
Loading stock research…

